Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies
- PMID: 39725515
- DOI: 10.1016/S1875-5364(24)60746-6
Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies
Abstract
The treatment of tumors continues to be significantly challenging. The presence of multiple modalities, including surgery, radiation, chemotherapy and immunotherapy, the therapeutic outcomes remain limited and are often associated with adverse effects and inconsistent efficacy across cancer types. Recent studies have highlighted the potential of active components from traditional Chinese medicine (TCM) for their anti-cancer properties, which are attributable to multi-targeted mechanisms and broad pharmacological actions. Despite this potential, TCM-derived compounds are commonly limited by poor water solubility, low bioavailability, and suboptimal targeting. Currently, it is believed that advances in nanotechnology could address these limitations. Nanoparticles (NPs), which possess properties such as enhanced bioavailability, controlled release and precise targeting, have been used to improve the therapeutic efficacy of TCM components in cancer therapy. This review discusses the use of NPs for the delivery of active TCM compounds via organic-inorganic nanocarriers, highlighting innovative strategies that enhance the effectiveness of TCM-based anti-tumor components to provide insights into improving clinical outcomes while advancing the modernization and global application of TCM in oncology.
Keywords: Nano drug delivery systems; Organic-inorganic nanocarriers; Traditional Chinese medicine.
Copyright © 2024 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Harnessing the Power of Traditional Chinese Medicine in Cancer Treatment: The Role of Nanocarriers.Int J Nanomedicine. 2025 Mar 13;20:3147-3174. doi: 10.2147/IJN.S502104. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40103746 Free PMC article. Review.
-
Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers.PeerJ. 2025 Apr 24;13:e19332. doi: 10.7717/peerj.19332. eCollection 2025. PeerJ. 2025. PMID: 40292112 Free PMC article. Review.
-
Review on anti-tumour lipid nano drug delivery systems of traditional Chinese medicine.J Drug Target. 2025 Jun;33(5):704-716. doi: 10.1080/1061186X.2024.2448708. Epub 2025 Jan 3. J Drug Target. 2025. PMID: 39743936 Review.
-
Progress in the treatment of Alzheimer's disease based on nanosized traditional Chinese medicines.J Mater Chem B. 2025 Jan 29;13(5):1548-1572. doi: 10.1039/d4tb02062f. J Mater Chem B. 2025. PMID: 39711283 Review.
-
Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy.J Nanobiotechnology. 2025 May 17;23(1):357. doi: 10.1186/s12951-025-03378-y. J Nanobiotechnology. 2025. PMID: 40382641 Free PMC article. Review.
Cited by
-
Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake.Acta Pharmacol Sin. 2025 May 15. doi: 10.1038/s41401-025-01562-2. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 40374895
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical